Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome (Q24246217)

acute respiratory distress syndrome

title

Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome (English)

0 references

main subject

1 reference

1 reference

1 reference

N Adhikari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

14 May 2020

K E A Burns

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

14 May 2020

M O Meade

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

18 October 2004

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

14 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

14 May 2020

page(s)

CD004477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized study

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Treatment with N-acetylcysteine during acute respiratory distress syndrome: A randomized, double-blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Bovine surfactant therapy for patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

HA-1A in septic patients with ARDS: results from the pivotal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Pulmonary Response of Massive Steroids in Seriously Injured Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Effect of surfactant on respiratory failure associated with thoracic aneurysm surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Filgrastim in patients with pneumonia and severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Effect of a Protective-Ventilation Strategy on Mortality in the Acute Respiratory Distress Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Surfactant supplementation in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Acute respiratory distress in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

N-acetylcysteine in experimental and clinical acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The use of corticosteroids in severe sepsis and acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Acute respiratory distress syndrome. Potential pharmacologic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Invited review: mechanisms of ventilator-induced lung injury: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Pharmacotherapy of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The statistical basis of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

One-year outcomes in survivors of the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Acute respiratory distress syndrome: pharmacological treatment options in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Anticoagulant therapy in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Role of exogenous surfactant in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Antioxidant therapy in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Acute lung injury and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Corticosteroid therapy in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Thirty years of clinical trials in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Clinical Trial Design and Outcomes in Patients with Severe Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Pharmacologic adjuncts during mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Epidemiology of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The future of surfactant therapy for patients with acute lung injury - new requirements and new surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Pharmacology of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Glucocorticoids and acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Genetic susceptibility to acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Group sequential clinical trials with triangular continuation regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Emerging systemic pharmacologic approaches in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

Liposomal prostaglandin E sub 1 in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

The influence of liposome-encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome

21 January 2018

1 reference

12 December 2020

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group

1 reference

12 December 2020

Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients

1 reference

12 December 2020

Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome

1 reference

12 December 2020

Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome

1 reference

12 December 2020

Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network

1 reference

12 December 2020

A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia

1 reference

12 December 2020

Surfactant replacement therapy

1 reference

12 December 2020

Octreotide treatment in patients with severe acute pancreatitis

1 reference

12 December 2020

Granulocyte colony-stimulating factor (G-CSF) stiffens leukocytes but attenuates inflammatory response without lung injury in septic patients

1 reference

12 December 2020

Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome

1 reference

12 December 2020

Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis

1 reference

12 December 2020

The effects of prostaglandin E1 on non-pulmonary organ function during clinical acute respiratory failure. The Prostaglandin E1 Study Group

1 reference

12 December 2020

Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study

1 reference

12 December 2020

Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition

1 reference

12 December 2020

Usefulness of a protease inhibitor (urinastatin) in ARDS with infectious diseases

1 reference

12 December 2020

Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome.

1 reference

12 December 2020

Indomethacin treatment of human adult respiratory distress syndrome

1 reference

12 December 2020

Functional and metabolic activity of polymorphonuclear leukocytes from patients with adult respiratory distress syndrome: results of a randomized double-blind placebo-controlled study on the activity of prostaglandin E1

1 reference

12 December 2020

Effect of aprotinin in adult respiratory distress syndrome

1 reference

12 December 2020

Prostaglandin E1 and right ventricular function in ARDS

1 reference

12 December 2020

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

1 reference

12 December 2020

Ketoconazole prevents acute respiratory failure in critically ill surgical patients

1 reference

12 December 2020

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

12 December 2020

Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS

1 reference

12 December 2020

Effects of prostaglandin E1 in adult respiratory distress syndrome.

1 reference

12 December 2020

Effectiveness of prostaglandin E1 in adult respiratory distress syndrome

1 reference

12 December 2020

Adult respiratory distress syndrome in cases of severe trauma--the prophylactic value of methylprednisolone sodium succinate

1 reference

12 December 2020

Early steroid therapy for respiratory failure

1 reference

12 December 2020

Dazoxiben in human sepsis and adult respiratory distress syndrome.

1 reference

12 December 2020

Prevention of the adult respiratory distress syndrome with dipyridamole

1 reference

12 December 2020

Prophylaxis of post-traumatic pulmonary insufficiency by protease-inhibitor therapy with aprotinin: a clinical study

1 reference

12 December 2020

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

1 reference

12 December 2020

[The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study]

1 reference

12 December 2020

Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis

1 reference

12 December 2020

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group

1 reference

12 December 2020

Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome

1 reference

12 December 2020

Posttraumatic lung syndrome. Definition, diagnosis, and therapy. Report of a double blind study

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.

1 reference

12 December 2020

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation

1 reference

12 December 2020

Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group

1 reference

12 December 2020

A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group

1 reference

12 December 2020

Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group

1 reference

12 December 2020

Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand.

1 reference

12 December 2020

Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS

1 reference

12 December 2020

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004477.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD004477.PUB2

2 references

Consolidated OpenCitations Corpus – April 2017

4482005

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

14 May 2020

4482005

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6517021&resulttype=core&format=json

14 May 2020

PubMed publication ID

15495113

2 references

Consolidated OpenCitations Corpus – April 2017

4482005